Mark Fendrick, MD, speaks about how how minority populations may be the most at risk following the Braidwood ruling on preventive care.
A. Mark Fendrick, MD, director of the Center for Value-Based Insurance Design at the University of Michigan and the co–editor in chief of The American Journal of Managed Care®, spoke about vulnerable populations should the Braidwood v Becerra ruling stand.
Transcript
What equity concerns could arise from the Braidwood v Becerra ruling?
Yeah, it's well known that if you make people pay more for something, they buy less of it. And it shouldn't surprise anyone that our own work and many others’ have shown that any level of cost sharing for any service is markedly impactful on underserved populations, such as those with low income and communities of color. So there are concerns from the get-go that any restoration of cost sharing at any amount for any of these 46 services will lead to meaningful declines in the utilization and associated with them is the clinical hardship that may come with the lack of early diagnosis and treatment.
Increased Interest in Advance Provision and Over-the-Counter Medication Abortion
January 16th 2025An increased public interest and support for medication abortion following the federal Supreme Court ruling, particularly among marginalized groups, suggests a shift towards more accessible and autonomous models of abortion care.
Read More
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
The study found significant disparities in the exposure to contaminants. Communities with higher percentages of Hispanic and Black residents were not only more likely to have unregulated chemicals in their drinking water, but they were also more frequently located near pollution sources.
Read More
BCI Shows Promise of Personalized Endocrine Therapy in Breast Cancer
January 15th 2025The Breast Cancer Index (BCI) may help identify patients with low-risk breast cancer who could potentially benefit from reduced endocrine therapy, leading to improved quality of life and potentially lower health care costs.
Read More